Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€5.16
21.01.24
-
21.01.25
-4.65%
03.02.24

Could be worthwhile Investment >10% per year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.08
21.01.24
-
21.01.25
21.10%
03.02.24

Could be worthwhile Investment >10% per year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.91
21.01.24
-
21.01.25
7.87%
03.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€75.00
21.01.24
-
21.01.25
-2.67%
03.02.24

Could be worthwhile Investment >10% per year
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€3.44
20.01.24
€1.00
20.01.25
3.49%
03.02.24

High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.95
18.01.24
-
18.01.25
-14.44%
21.01.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.98
18.01.24
-
18.01.25
-3.63%
20.01.24

Could be worthwhile Investment >10% per year
buy
Ascendis Ph.sp.adr 1 Dk 1

Start price
Target price
Perf. (%)
€122.00
17.01.24
-
17.01.25
-2.46%
31.01.24

buy
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€1.32
09.01.24
-
09.01.25
-6.06%
20.01.24

Could be worthwhile Investment >10% per year
buy
Grifols S.A.

Start price
Target price
Perf. (%)
€9.54
09.01.24
-
09.01.25
24.03%
10.01.24

Could be worthwhile Investment >10% per year
Good culture
Few uniques
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€5.79
07.01.24
-
07.01.25
-10.88%
20.01.24

Could be worthwhile Investment >10% per year
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.78
07.01.24
-
07.01.25
9.88%
03.03.24

Could be worthwhile Investment >10% per year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.62
07.01.24
-
07.01.25
-11.80%
20.01.24

Could be worthwhile Investment >10% per year
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.02
07.01.24
-
07.01.25
-16.47%
19.01.24

Probably not worthwhile Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€35.35
05.01.24
-
0.00%
05.01.24

Could be worthwhile Investment >10% per year
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.74
03.01.24
-
03.01.25
-3.65%
06.01.24

Risky Investment
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.89
30.12.23
€5.50
30.12.24
-22.39%
10.02.24

Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.64
28.12.23
-
28.12.24
-9.11%
06.01.24

Risky Investment
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.60
27.12.23
-
27.12.24
12.33%
21.01.24

Could be very worthwhile Investment >20% year
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.83
27.12.23
-
27.12.24
-2.62%
07.01.24

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.60
27.12.23
€3.00
27.12.24
13.68%
28.12.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.06
26.12.23
-
26.12.24
-8.96%
11.01.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€4.16
26.12.23
-
26.12.24
-8.05%
19.01.24

Could be worthwhile Investment >10% per year